![Devon Cayer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Devon Cayer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Myi Diagnostics & Discovery, Inc.
![]() Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 08.09.2015 | - |
Gründer | 08.09.2015 | - |
Karriereverlauf von Devon Cayer
Ehemalige bekannte Positionen von Devon Cayer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
1859, Inc.
![]() 1859, Inc. BiotechnologyHealth Technology 1859, Inc. operates as a biotechnology company focuses on discovery and development of next-generation therapeutics. The company was founded by Devon Cayer, Andrew MacConnell, Ramesh Ramji, and Sara Thrall and is headquartered in Del Mar, CA. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
Gründer | - | - |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Myi Diagnostics & Discovery, Inc.
![]() Myi Diagnostics & Discovery, Inc. BiotechnologyHealth Technology MYi Diagnostics & Discovery, Inc. provides diagnostic assays for longitudinal profiling of blood and other tissues applicable to the monitoring of healthy, disease-predisposed, and treated individuals. The firm also develops multiplexed immunocytochemical analytical platforms for assaying patient biopsies to identify the unique biomarkers that identify diseased cells. The company was founded by Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor on September 8, 2015 and is headquartered in San Diego, CA. | Health Technology |
1859, Inc.
![]() 1859, Inc. BiotechnologyHealth Technology 1859, Inc. operates as a biotechnology company focuses on discovery and development of next-generation therapeutics. The company was founded by Devon Cayer, Andrew MacConnell, Ramesh Ramji, and Sara Thrall and is headquartered in Del Mar, CA. | Health Technology |
- Börse
- Insiders
- Devon Cayer
- Erfahrung